Trial Profile
Clinical Trials Insight: 700029084
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2007
Price :
$35
*
At a glance
- Drugs RDEA 806 (Primary)
- Indications Gout; HIV infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Ardea Biosciences
- 05 Dec 2007 New trial record.